Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gamijinhae-tang (GJHT) is a traditional Korean herbal medicine (Hanbang) formulation primarily utilized for the treatment of respiratory disorders characterized by inflammation and cough. As a modified version of the base Jinhae-tang formula, it typically consists of a complex mixture of medicinal herbs such as *Platycodon grandiflorum* and *Glycyrrhiza uralensis*. Pharmacological studies, including those using porcine pancreatic elastase (PPE) and lipopolysaccharide (LPS) induced models, demonstrate that GJHT exerts potent anti-inflammatory effects. Its mechanism of action involves the suppression of pro-inflammatory mediators, specifically reducing the levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), and inhibiting the recruitment of neutrophils into the airways. These properties suggest potential therapeutic utility in managing acute lung injury (ALI) and chronic obstructive pulmonary disease (COPD).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gamijinhae-tang.